Novo Nordisk A/S (ADR) (NYSE:NVO)

CAPS Rating: 4 out of 5

Engaged in discovery, development, manufacturing and marketing of pharmaceutical products and has two business segments - diabetes care and biopharmaceuticals.

Recs

0
Player Avatar chang07 (47.47) Submitted: 4/25/2011 9:03:22 PM : Outperform Start Price: $127.28 NVO Score: +11.93

Victoza...any questions?

Report this Post Reply

Featured Broker Partners


Advertisement